Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)
NCT04317092
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
402
Enrollment
OTHER
Sponsor class
Conditions
COVID-19 Pneumonia
Interventions
DRUG:
Tocilizumab Injection
Sponsor
National Cancer Institute, Naples